The BRICS Cancer Therapeutics Market Outlook (2021-2031) reflects a rapidly expanding healthcare sector driven by rising cancer incidence, improving medical infrastructure, and increasing access to advanced treatment options. The BRICS nations—Brazil, Russia, India, China, and South Africa—are experiencing a growing burden of cancer due to aging populations,...
According to a new report from Intel Market Research, the global Palonosetron market was valued at USD 110 million in 2024 and is projected to reach USD 148 million by 2034, growing at a CAGR of 4.4% during the forecast period (2025–2034). This growth is fueled by rising cancer incidence globally and increasing adoption of chemotherapy protocols requiring effective antiemetic solutions....
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek